Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
Study Details
Study Description
Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with mitomycin, doxorubicin, and cisplatin in treating patients with recurrent or advanced cancer of the uterus.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Detailed Description
OBJECTIVES: I. Estimate the antitumor activity of the combination of mitomycin, doxorubicin, and cisplatin (MAP) in patients with recurrent or advanced uterine sarcomas. II. Determine the nature and degree of toxicity of MAP chemotherapy in this cohort of patients.
OUTLINE: Patients receive IV doxorubicin, mitomycin, and cisplatin over 3 hours once every 3 weeks, for a minimum of 1 course. Patients who have complete response, partial response, or stable disease will continue for at least 3 courses. If side effects are not severe, patients may remain on the study regimen at the investigator's discretion for a maximum of 6 courses. All patients are followed until death.
PROJECTED ACCRUAL: The first stage of accrual is anticipated to accrue 20 evaluable patients in approximately 12 months. If indicated, a second stage will accrue approximately 10 evaluable patients.
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
DISEASE CHARACTERISTICS: Histologically confirmed advanced, persistent, or recurrent uterine sarcoma Documented disease progression after local therapy Measurable disease consisting of abdominal, pelvic, chest, or other masses that can be defined in at least two dimensions by palpation, x-ray, computed tomography or ultrasound
PATIENT CHARACTERISTICS: Age: No age specified Performance status: Karnofsky 50%-100% Life expectancy: Not specified Hematopoietic: WBC at least 3,000/mm3 Granulocyte count at least 1,500/mm3 Platelet count at least 100,000/mm3 Hepatic: Bilirubin no greater than 1.5 times normal SGOT no greater than 3 times normal Alkaline phosphatase no greater than 3 times normal Renal: Creatinine no greater than 1.5 times normal Cardiovascular: Ejection fraction within institutional normal limits Pulmonary: Not specified Other: No active infection No concurrent second malignancy other than nonmelanoma skin cancer Must be disease free of any prior malignancy for at least 5 years and not received any treatments with chemotherapy or radiation therapy for that malignancy
PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior chemotherapy Endocrine therapy: Not specified Radiotherapy: At least 6 weeks since radiotherapy Recovered from effects of radiotherapy Surgery: Recovered from effects of surgery
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Alabama Comprehensive Cancer Center | Birmingham | Alabama | United States | 35294 |
2 | USC/Norris Comprehensive Cancer Center | Los Angeles | California | United States | 90033-0800 |
3 | Jonsson Comprehensive Cancer Center, UCLA | Los Angeles | California | United States | 90095-1781 |
4 | Chao Family Comprehensive Cancer Center | Orange | California | United States | 92868 |
5 | Women's Cancer Center | Palo Alto | California | United States | 94304 |
6 | University of Colorado Cancer Center | Denver | Colorado | United States | 80262 |
7 | Vincent T. Lombardi Cancer Research Center, Georgetown University | Washington | District of Columbia | United States | 20007 |
8 | Walter Reed Army Medical Center | Washington | District of Columbia | United States | 20307-5000 |
9 | H. Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | United States | 33612 |
10 | Emory University Hospital - Atlanta | Atlanta | Georgia | United States | 30322 |
11 | MBCCOP - Hawaii | Honolulu | Hawaii | United States | 96813 |
12 | Rush-Presbyterian-St. Luke's Medical Center | Chicago | Illinois | United States | 60612 |
13 | University of Chicago Cancer Research Center | Chicago | Illinois | United States | 60637 |
14 | Indiana University Cancer Center | Indianapolis | Indiana | United States | 46202-5265 |
15 | University of Iowa Hospitals and Clinics | Iowa City | Iowa | United States | 52242 |
16 | Albert B. Chandler Medical Center, University of Kentucky | Lexington | Kentucky | United States | 40536-0084 |
17 | Johns Hopkins Oncology Center | Baltimore | Maryland | United States | 21287 |
18 | Medicine Branch | Bethesda | Maryland | United States | 20892 |
19 | Radiation Oncology Branch | Bethesda | Maryland | United States | 20892 |
20 | University of Massachusetts Memorial Medical Center | Worcester | Massachusetts | United States | 01655 |
21 | CCOP - Ann Arbor Regional | Ann Arbor | Michigan | United States | 48106 |
22 | Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | United States | 48201 |
23 | University of Minnesota Cancer Center | Minneapolis | Minnesota | United States | 55455 |
24 | University of Mississippi Medical Center | Jackson | Mississippi | United States | 39216-4505 |
25 | Washington University School of Medicine | Saint Louis | Missouri | United States | 63110 |
26 | CCOP - Southern Nevada Cancer Research Foundation | Las Vegas | Nevada | United States | 89106 |
27 | Cooper Hospital/University Medical Center | Camden | New Jersey | United States | 08103 |
28 | Cancer Center of Albany Medical Center | Albany | New York | United States | 12208 |
29 | State University of New York Health Science Center at Brooklyn | Brooklyn | New York | United States | 11203 |
30 | North Shore University Hospital | Manhasset | New York | United States | 11030 |
31 | Memorial Sloan-Kettering Cancer Center | New York | New York | United States | 10021 |
32 | University of Rochester Cancer Center | Rochester | New York | United States | 14642 |
33 | State University of New York Health Sciences Center - Stony Brook | Stony Brook | New York | United States | 11790-9832 |
34 | Lineberger Comprehensive Cancer Center, UNC | Chapel Hill | North Carolina | United States | 27599-7295 |
35 | Duke Comprehensive Cancer Center | Durham | North Carolina | United States | 27710 |
36 | Comprehensive Cancer Center of Wake Forest University Baptist Medical Center | Winston-Salem | North Carolina | United States | 27157-1082 |
37 | Barrett Cancer Center, The University Hospital | Cincinnati | Ohio | United States | 45219 |
38 | Ireland Cancer Center | Cleveland | Ohio | United States | 44106-5065 |
39 | Cleveland Clinic Cancer Center | Cleveland | Ohio | United States | 44195 |
40 | Arthur G. James Cancer Hospital - Ohio State University | Columbus | Ohio | United States | 43210 |
41 | University of Oklahoma College of Medicine | Oklahoma City | Oklahoma | United States | 73190 |
42 | Abington Memorial Hospital | Abington | Pennsylvania | United States | 19001 |
43 | Milton S. Hershey Medical Center | Hershey | Pennsylvania | United States | 17033 |
44 | University of Pennsylvania Cancer Center | Philadelphia | Pennsylvania | United States | 19104 |
45 | Kimmel Cancer Center of Thomas Jefferson University - Philadelphia | Philadelphia | Pennsylvania | United States | 19107 |
46 | Pennsylvania Hospital | Philadelphia | Pennsylvania | United States | 19107 |
47 | Fox Chase Cancer Center | Philadelphia | Pennsylvania | United States | 19111 |
48 | Medical University of South Carolina | Charleston | South Carolina | United States | 29425-0721 |
49 | CCOP - Upstate Carolina | Spartanburg | South Carolina | United States | 29303 |
50 | Simmons Cancer Center - Dallas | Dallas | Texas | United States | 75235-9154 |
51 | University of Texas - MD Anderson Cancer Center | Houston | Texas | United States | 77030 |
52 | Cancer Center, University of Virginia HSC | Charlottesville | Virginia | United States | 22908 |
53 | University of Washington Medical Center | Seattle | Washington | United States | 98195-6043 |
54 | Tacoma General Hospital | Tacoma | Washington | United States | 98405 |
Sponsors and Collaborators
- Gynecologic Oncology Group
- National Cancer Institute (NCI)
Investigators
- Study Chair: John H. Edmonson, MD, Mayo Clinic
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CDR0000065540
- GOG-87I